Consolidated Statements of Stockholders' Equity - USD ($)	Preferred Stock [Member] Series A Preferred Stock [Member]	Preferred Stock [Member] Series B Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	AOCI Attributable to Parent [Member]	Retained Earnings [Member]	Alset E Home International Stockholders Equity [Member]	Noncontrolling Interest [Member]	Total
Balance at Dec. 31, 2019			$ 10,001	$ 56,786,713	$ 1,458,289	$ (41,758,640)	$ 16,496,362	$ 7,163,857	$ 23,660,219
Balance, shares at Dec. 31, 2019			10,001,000
Cancellation of Outstanding Stock			$ (3,601)	3,601
Cancellation of Outstanding Stock, shares			(3,601,000)
Issuance of Common Stock			$ 2,170	13,199,953			13,202,123		13,202,123
Issuance of Common Stock, shares			2,170,000
Subsidiary’s Issuance of Stock				13,439,082			13,439,082	8,748,744	22,187,826
Proceeds from Selling Subsidiary Equity				278,346			278,346	208,954	487,300
Sale of Impact BioMedical Inc. to Related Party				26,307,872			26,307,872	19,846,288	46,154,160
Contribution				539,088			539,088	406,681	945,769
Transfer iGalen International Inc. to Related Party				2,132,407			2,132,407	1,608,658	3,741,065
Change in Non-Controlling Interest				(9,957,118)	19,047		(9,938,071)	1,897,608	(8,040,463)
Change in Unrealized Gain (Loss) on Investment					11,130		11,130	8,356	19,486
Foreign Currency Translations					654,872		654,872	494,026	1,148,898
Distribution to Non-Controlling Shareholders								(411,250)	(411,250)
Net Loss						(3,151,657)	(3,151,657)	(1,948,661)	(5,100,318)
Transactions under Common Control
Balance at Dec. 31, 2020			$ 8,570	102,729,944	2,143,338	(44,910,297)	59,971,555	38,023,260	97,994,815
Balance, shares at Dec. 31, 2020			8,570,000
Issuance of Common Stock			$ 67,502	104,498,157			104,565,659		104,565,659
Issuance of Common Stock, shares			67,502,481
Subsidiary’s Issuance of Stock				2,328,707			2,328,707	920,632	3,249,339
Proceeds from Selling Subsidiary Equity				164,107			164,107	115,893	280,000
Contribution
Transfer iGalen International Inc. to Related Party
Change in Non-Controlling Interest				(5,729,539)	865,493		(4,864,046)	2,664,056	(2,199,990)
Change in Unrealized Gain (Loss) on Investment					(41,273)		(41,273)	(15,906)	(57,179)
Foreign Currency Translations					(2,625,912)		(2,625,912)	(1,349,054)	(3,974,966)
Distribution to Non-Controlling Shareholders								(2,549,750)	(2,549,750)
Net Loss						(103,323,176)	(103,323,176)	(15,694,415)	(119,017,591)
Convert Common stock to Series A Preferred Stock	$ 6		$ (6,380)	6,374
Convert Common stock to Series A Preferred Stock, shares	6,380		(6,380,000)
Convert Related Party Note Payable to Series B Preferred Stock		$ 2		12,999,998			13,000,000		13,000,000
Convert Related Party Note Payable to Series B Preferred Stock, shares		2,132
Convert Preferred Stock Series A and B to Common	$ (6)	$ (2)	$ 8,512	(8,504)
Convert Preferred Stock Series A and B to Common, shares	(6,380)	(2,132)	8,512,000
Transactions under Common Control				(57,190,499)			(57,190,499)		(57,190,499)
Sale of Vivacitas to Related Party				2,279,872			2,279,872		2,279,872
Purchase Stock of True Partner from Related Party				3,274,060			3,274,060		3,274,060
Beneficial Conversion Feature Intrinsic Value, Net				50,770,192			50,770,192		50,770,192
Convert Related Party Note Payable to Common Stock			$ 9,164	51,217,402			51,226,566		51,226,566
Convert Related Party Note Payable to Common Stock, shares			9,163,965
Deconsolidate American Pacific Bancorp				28,287,920			28,287,920	(383,063)	27,904,857
Exercise American Premium Water Warrant to Purchase Stock				553,786			553,786	180,614	734,400
Balance at Dec. 31, 2021			$ 87,368	$ 296,181,977	$ 341,646	$ (148,233,473)	$ 148,377,518	$ 21,912,268	$ 170,289,786
Balance, shares at Dec. 31, 2021			87,368,446